on 01 May 2024
Last Applicant/ Owned by
Fulcrum Therapeutics, Inc.
26 Landsdowne StreetCambridge MA 02139
US
Serial Number
2236799 filed on 09th Sep 2022
Correspondent Address
480-THE STATION, 601 WEST CORDOVA STREETVANCOUVER
BRITISH COLUMBIA
CA
V6B1G1
RISE
Vienna Information
1 . 7 . 6
Crescent moon, half-moonCroissant, demi-lune
26 . 2 . 1
Segments of circles or ellipses (except 26.2.7)Segments de cercle ou d'ellipse (excepté 26.2.7)
26 . 4 . 2
RectanglesRectangles
26 . 4 . 5
One quadrilateralUn quadrilatère
26 . 4 . 12
Quadrilaterals containing one or more other geometrical figures -- Note: Including quadrilaterals containing bent or straight lines (except 26.4.11).Quadrilatères contenant une ou plusieurs autres figures géométriques -- Note: Y compris les quadrilatères contenant des lignes courbées ou droites (excepté 26.4.11).
26 . 4 . 13
Quadrilaterals containing representations of heavenly bodies or natural phenomenaQuadrilatères contenant la représentation de corps célestes ou de phénomènes naturels
26 . 4 . 18
Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres
27 . 5 . 1
Letters presenting a special form of writingLettres présentant un graphisme spécial
27 . 5 . 8
Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.
Trademark usage description
clinical research in the field of sickle cell disease; testing of pharmaceutical preparations for treatment of sickle cell disease; inspection of phar Read MoreClassification Information
Class [042]
Clinical research in the field of Sickle Cell Disease; testing of pharmaceutical preparations for treatment of Sickle Cell Disease; inspection of pharmaceutical preparations for treatment of Sickle Cell Disease; research of pharmaceutical preparations for treatment of Sickle Cell Disease; development of pharmaceutical preparations for treatment of Sickle Cell Disease; pharmaceutical products development; development of pharmaceutical preparations and medicines.
Classification kind code
11
Class [044]
Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals.
Classification kind code
11
Mark Details
Serial Number
2236799
Mark Type
Trademark
Legal History
| Action Taken | Status |
|---|---|
| Submitted for opposition 48 on 21st May 2024 | Agent Changed |
| Submitted for opposition 22 on 01st May 2024 | Search Recorded |
| Submitted for opposition 20 on 01st May 2024 | Examiner's First Report |
| Submitted for opposition 223 on 01st May 2024 | Total Provisional Refusal |
| Submitted for opposition 256 on 04th Dec 2023 | Notification of Possible Opposition Sent |
| Submitted for opposition 257 on 02th Feb 2023 | Designation Notification - Madrid Protocol |
| Submitted for opposition 31 on 01st Feb 2023 | Formalized |
| Submitted for opposition 1 on 01st Feb 2023 | Created |
| Submitted for opposition 228 on 09th Sep 2022 | International Registration |
| Submitted for opposition 30 on 09th Sep 2022 | Filed |